Meeting
2015 Gastrointestinal Cancers Symposium
Safety analysis of FOLFOX as adjuvant chemotherapy for stage III colon cancer in phase II study (NORTH/HGCSG1003): Detailed analysis of peripheral sensory neuropathy.
Authors
Susumu Sogabe
Department of Internal Medicine, Kushiro Rosai Hospital, Kushiro, Japan
Susumu Sogabe , Satoshi Yuki , Hiraku Fukushima , Norihiko Takahashi , Toshiaki Shichinohe , Takaya Kusumi , Fumitaka Nakamura , Ichiro Iwanaga , Kazuteru Hatanaka , Kencho Miyashita , Jun Konno , Kazuhito Uemura , Masaaki Nenohi , Masaya Kina , Naoya Sakamoto , Akinobu Taketomi , Satoshi Hirano , Toraji Amano , Yoichi M Ito , Yoshito Komatsu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
000004590
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 701)
DOI
10.1200/jco.2015.33.3_suppl.701
Abstract #
701
Poster Bd #
D43
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer (NORTH/HGCSG1003).
First Author: Toshiaki Shichinohe
Poster
2018 ASCO Annual Meeting
Effect of age, gender, and performance status (PS) on the duration results of adjuvant chemotherapy for stage III colon cancer: The IDEA collaboration.
First Author: Anthony Frank Shields
Poster
2018 Gastrointestinal Cancers Symposium
Prospective multicenter study of the impact of the 12-gene assay recurrence score on adjuvant chemotherapy treatment recommendations for stage II/III colon cancer in the post-IDEA era: SUNRISE-Decision Impact study.
First Author: Takeharu Yamanaka
Poster
2016 Gastrointestinal Cancers Symposium
“Real world” effectiveness of different postoperative adjuvant chemotherapy regimens in stage III colon cancer patients.
First Author: Jy Ming Chiang